Treatment of post-allogeneic stem cell transplant cytopenias with sequential doses of mesenchymal stromal cells: results of a multicenter Phase II trial

被引：0
|
作者：
Veiga, A. [1 ]
Redondo, A. [1 ]
Villaron, E. [1 ]
Lopez-Parra, M. [1 ]
Arratibel, N. [1 ]
Baile, M. [1 ]
Lopez-Villar, O. [1 ]
Cabrero, M. [1 ]
Perez, E. [1 ]
Lopez-Corral, L. [1 ]
Vazquez, L. [1 ]
Perez-Simon, J. A. [2 ]
Prosper, F. [3 ]
Caballero, M. D. [1 ]
Canizo, M. C. D. [1 ]
Sanchez-Guijo, F. [1 ]
机构：
[1] Hosp Univ Salamanca, IBSAL, Salamanca, Spain
[2] Hosp Virgen del Rocio, IBIS, Seville, Spain
[3] Clin Univ Navarra, Navarra, Spain
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O081
引用
收藏
页码：S58 / S59
页数：2
相关论文
共 50 条
  • [31] Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial
    Sun, Qipeng
    Huang, Zhengyu
    Han, Fei
    Zhao, Ming
    Cao, Ronghua
    Zhao, Daqiang
    Hong, Liangqing
    Na, Ning
    Li, Heng
    Miao, Bin
    Hu, Jianmin
    Meng, Fanhang
    Peng, Yanwen
    Sun, Qiquan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [32] Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial
    Qipeng Sun
    Zhengyu Huang
    Fei Han
    Ming Zhao
    Ronghua Cao
    Daqiang Zhao
    Liangqing Hong
    Ning Na
    Heng Li
    Bin Miao
    Jianmin Hu
    Fanhang Meng
    Yanwen Peng
    Qiquan Sun
    Journal of Translational Medicine, 16
  • [33] Phase II human trial of autologous mesenchymal stem cell transplantation for the treatment of decompensated cirrhosis
    Alimoghaddam, K.
    Mohamadnejad, M.
    Bagheri, M.
    Bashtar, M.
    Ghanati, H.
    Bonab, M. Mohyedin
    Ghavamzadeh, A.
    Malekzadeh, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S318 - S319
  • [34] Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
    Servais, Sophie
    Baron, Frederic
    Lechanteur, Chantal
    Seidel, Laurence
    Baudoux, Etienne
    Briquet, Alexandra
    Selleslag, Dominik
    Maertens, Johan
    Poire, Xavier
    Schroyens, Wilfried
    Graux, Carlos
    De Becker, Ann
    Zachee, Pierre
    Ory, Aurelie
    Herman, Julie
    Kerre, Tessa
    Beguin, Yves
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial
    Ranjbar, Amin
    Hassanzadeh, Halimeh
    Jahandoust, Faezeh
    Miri, Raheleh
    Bidkhori, Hamid Reza
    Monzavi, Seyed Mostafa
    Sanjar-Moussavi, Nasser
    Matin, Maryam M.
    Shariati-Sarabi, Zhaleh
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2022, 70 (02)
  • [36] Infusion of Mesenchymal Stromal Cells Can Aid Hematopoietic Recovery Following Allogeneic Hematopoietic Stem Cell Myeloablative Transplant: A Pilot Study
    Meuleman, Nathalie
    Tondreau, Tatiana
    Ahmad, Imran
    Kwan, John
    Crokaert, Francoise
    Delforge, Alain
    Dorval, Christine
    Martiat, Philippe
    Lewalle, Philippe
    Lagneaux, Laurence
    Bron, Dominique
    STEM CELLS AND DEVELOPMENT, 2009, 18 (09) : 1247 - 1252
  • [37] Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results
    Liu, Z.
    Zhang, Y.
    Xiao, H.
    Yao, Z.
    Zhang, H.
    Liu, Q.
    Wu, B.
    Nie, D.
    Li, Y.
    Pang, Y.
    Fan, Z.
    Li, L.
    Jiang, Z.
    Duan, F.
    Li, H.
    Zhang, P.
    Gao, Y.
    Ouyang, L.
    Yue, C.
    Xie, M.
    Shi, C.
    Xiao, Y.
    Wang, S.
    BONE MARROW TRANSPLANTATION, 2017, 52 (05) : 704 - 710
  • [38] Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results
    Z Liu
    Y Zhang
    H Xiao
    Z Yao
    H Zhang
    Q Liu
    B Wu
    D Nie
    Y Li
    Y Pang
    Z Fan
    L Li
    Z Jiang
    F Duan
    H Li
    P Zhang
    Y Gao
    L Ouyang
    C Yue
    M Xie
    C Shi
    Y Xiao
    S Wang
    Bone Marrow Transplantation, 2017, 52 : 704 - 710
  • [39] A phase II trial of autologous stem cell transplant (AHSCT) followed by mini-allogeneic stem cell transplant (AlloTx) for the treatment of multiple myeloma: Analysis of ECOG E4A98
    Vesole, David H.
    Zhang, Lijun
    Flomenberg, Neal
    Greipp, Philip R.
    Lazarus, Hillard M.
    BLOOD, 2007, 110 (11) : 889A - 889A
  • [40] Allogeneic Mesenchymal Stem Cells as Induction Therapy Are Safe and Feasible in Renal Allografts: Pilot Results of a Multicenter Randomized Controlled Trial.
    Sun, Q.
    Han, F.
    Zhao, M.
    Cao, R.
    Zhao, D.
    Huang, Z.
    Hong, L.
    Peng, Y.
    Sun, Q.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 974 - 975
12345